The group's principle activity is to provide drug development and therapy research services. The group also provides data management, pharmacovigilance, medical writing, clinical pharmacology, and health policy and strategic reimbursement services. The group's services include clinical research trials, experimental medicine, early drug development, and biostatistics and analytics. The group operates from United States.
